20 Maxwell House, Singapore, Jan. 25, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global gene therapy market is expected to...
Benzinga - Gilead Sciences (NASDAQ:GILD)'s (NASDAQ:GILD) short percent of float has fallen 15.71% since its last report. The company recently reported that it has 14.76 million...
By Senad Karaahmetovic RBC Capital Markets analysts downgraded shares of Gilead Sciences (NASDAQ:GILD) to Peer Perform from Outperform with a price target of $87 per share,...
Stocks surged in July, with the major indexes enjoying their best gains since 2020. But the market is still off substantially for the year. The rally came despite the Federal...
The COVID-19 pandemic highlighted the importance of health care and the role biopharma companies play in drug and vaccine development. As a result, the sector grew tremendously...
Biotechnology stocks represent companies that research, develop or market healthcare-related therapies or products. They typically use living organisms, biological systems, or...
Gilead Sciences, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of medicine to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company’s products for HIV/AIDS patients include Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. Its COVID-19 product is Veklury. The products for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. The products under hematology/oncology/cell therapy include Yescarta, Tecartus, Trodelvy, and Zydelig. The other products include Letairis (ambrisentan), Ranexa (ranolazine), Cayston, Jyseleca, and AmBisome (amphotericin B liposome for injection). The Company also sells and distributes generic versions of Epclusa and Harvoni in the United States. The Company is also focused on restoring immune balance with agonists targeting immune inhibitory receptors.
| Average | 86.22 (+2.97% Upside) |
| High | 111.00 |
| Low | 63.00 |
| Price | 83.73 |
| No. of Analysts | 23 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Sell | Strong Buy |
| Technical Indicators | Sell | Sell | Strong Sell | Strong Sell | Strong Buy |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 110.20 | 112.30 | 108.30 | -3.28 | -2.89% | 63.80M | London | |||
| 171.34 | 171.48 | 169.46 | +0.16 | +0.09% | 15.60M | London | |||
| 1.10 | 1.10 | 1.10 | 0.00 | 0.00% | 0.00 | London | |||
| 1,371.50 | 1,381.50 | 1,357.50 | 0.00 | 0.00% | 3.75M | London | |||
| 146.20 | 147.30 | 145.05 | +0.65 | +0.45% | 7.70M | London | |||
| 600.50 | 603.60 | 596.50 | -3.40 | -0.56% | 20.03M | London | |||
| 152.80 | 155.00 | 145.00 | +6.60 | +4.51% | 4.02M | London | |||
| 129.90 | 130.75 | 128.10 | +0.80 | +0.62% | 12.01M | London | |||
| 124.50 | 125.10 | 122.40 | +0.70 | +0.56% | 2.19M | London | |||
| 1,194.00 | 1,200.00 | 1,173.00 | -1.00 | -0.08% | 312.68K | London | |||
| 212.30 | 212.40 | 209.40 | +1.70 | +0.81% | 3.18M | London | |||
| 507.20 | 521.40 | 501.40 | -7.80 | -1.51% | 6.05M | London | |||
| 768.50 | 770.00 | 753.00 | +11.50 | +1.52% | 534.66K | London | |||
| 17.50 | 17.50 | 17.45 | +0.50 | +2.94% | 34.22K | London | |||
| 1,122.00 | 1,132.00 | 1,118.00 | -13.50 | -1.19% | 2.89M | London |